Senate Bill S5935

Vetoed By Governor
2019-2020 Legislative Session

Relates to medication assisted treatment for substance use disorders

download bill text pdf

Sponsored By

Archive: Last Bill Status - Vetoed by Governor

  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Vetoed By Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

Bill Amendments

co-Sponsors

2019-S5935 - Details

Law Section:
Social Services Law
Laws Affected:
Amd §§365-a & 364-j, Soc Serv L; amd §273, Pub Health L

2019-S5935 - Summary

Relates to medication assisted treatment for substance abuse disorders; prohibits prior authorization.

2019-S5935 - Sponsor Memo

2019-S5935 - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   5935
 
                        2019-2020 Regular Sessions
 
                             I N  S E N A T E
 
                               May 16, 2019
                                ___________
 
 Introduced  by Sen. HARCKHAM -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the social services law and the public  health  law,  in
   relation to medication for the treatment of substance use disorders
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 2 of section 365-a of the social  services  law
 is amended by adding a new paragraph (gg) to read as follows:
   (GG)  ALL UNITED STATES FOOD AND DRUG ADMINISTRATION APPROVED FORMS OF
 MEDICATION ASSISTED TREATMENT PRESCRIBED ACCORDING TO GENERALLY ACCEPTED
 NATIONAL PROFESSIONAL GUIDELINES FOR THE TREATMENT OF  A  SUBSTANCE  USE
 DISORDER.    SUCH  MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO
 ANY PRIOR AUTHORIZATION MANDATE.
   § 2. Subdivision 26-b of section 364-j of the social services law,  as
 added  by  section  4  of  part  B of chapter 69 of the laws of 2016, is
 amended to read as follows:
   26-b. Managed care providers shall not require prior authorization for
 [an initial or renewal  prescription  for  buprenorphine  or  injectable
 naltrexone   for  detoxification  or  maintenance  treatment  of  opioid
 addiction unless the prescription is for a non-preferred  or  non-formu-
 lary  form of the drug or as otherwise required by section 1927(k)(6) of
 the Social Security Act] ANY UNITED STATES FOOD AND DRUG  ADMINISTRATION
 APPROVED  FORMS OF MEDICATION ASSISTED TREATMENT PRESCRIBED ACCORDING TO
 GENERALLY ACCEPTED NATIONAL PROFESSIONAL GUIDELINES FOR THE TREATMENT OF
 A SUBSTANCE USE DISORDER.
   § 3. Subdivision 10 of section 273 of the public health law, as  added
 by  section 5 of part B of chapter 69 of the laws of 2016, is amended to
 read as follows:
   10. Prior authorization shall not  be  required  for  [an  initial  or
 renewal  prescription  for  buprenorphine  or  injectable naltrexone for
 detoxification or maintenance treatment of opioid addiction  unless  the

  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

co-Sponsors

2019-S5935A (ACTIVE) - Details

Law Section:
Social Services Law
Laws Affected:
Amd §§365-a & 364-j, Soc Serv L; amd §273, Pub Health L

2019-S5935A (ACTIVE) - Summary

Relates to medication assisted treatment for substance abuse disorders; prohibits prior authorization.

2019-S5935A (ACTIVE) - Sponsor Memo

2019-S5935A (ACTIVE) - Bill Text download pdf 

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                  5935--A
     Cal. No. 1170
 
                        2019-2020 Regular Sessions
 
                             I N  S E N A T E
 
                               May 16, 2019
                                ___________
 
 Introduced by Sens. HARCKHAM, BIAGGI, CARLUCCI, KAPLAN -- read twice and
   ordered  printed, and when printed to be committed to the Committee on
   Health -- committee discharged and said bill committed to the  Commit-
   tee  on  Rules -- reported favorably from said committee, ordered to a
   third reading,  passed  by  Senate  and  delivered  to  the  Assembly,
   recalled,  vote  reconsidered,  restored to third reading, amended and
   ordered reprinted, retaining its place in the order of third reading
 
 AN ACT to amend the social services law and the public  health  law,  in
   relation to medication for the treatment of substance use disorders
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. Subdivision 2 of section 365-a of the social  services  law
 is amended by adding a new paragraph (gg) to read as follows:
   (GG)  ALL  BUPRENORPHINE PRODUCTS, METHADONE OR LONG ACTING INJECTABLE
 NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT  OF  A  SUBSTANCE
 USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED NATIONAL PROFES-
 SIONAL  GUIDELINES  FOR THE TREATMENT OF A SUBSTANCE USE DISORDER.  SUCH
 MEDICATION ASSISTED TREATMENT SHALL NOT BE SUBJECT TO ANY PRIOR AUTHORI-
 ZATION MANDATE.
   § 2. Subdivision 26-b of section 364-j of the social services law,  as
 added  by  section  4  of  part  B of chapter 69 of the laws of 2016, is
 amended to read as follows:
   26-b. Managed care providers shall not require prior authorization for
 [an initial or renewal  prescription  for  buprenorphine  or  injectable
 naltrexone   for  detoxification  or  maintenance  treatment  of  opioid
 addiction unless the prescription is for a non-preferred  or  non-formu-
 lary  form of the drug or as otherwise required by section 1927(k)(6) of
 the Social Security Act] ANY BUPRENORPHINE PRODUCTS, METHADONE  OR  LONG
 ACTING INJECTABLE NALTREXONE FOR DETOXIFICATION OR MAINTENANCE TREATMENT
 OF  A  SUBSTANCE USE DISORDER PRESCRIBED ACCORDING TO GENERALLY ACCEPTED
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.